Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joungho Han

Showing results (241-250 of 313) with videos related to

Pageof 32
Sort By:
Cancer|January 7, 2010
Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarrayHyeong Su Kim, Yeon Hee Park, Jeeyun Lee, et al.
Cancer|July 16, 2008
ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapyIn Gyu Hwang, Myung Ju Ahn, Byeong Bae Park, et al.
Transplantation|May 15, 2007
Improvement of kidney failure with fetal kidney precursor cell transplantationSang-Soo Kim, Heung Jae Park, Joungho Han, et al.
Cancer Research and Treatment|December 19, 2015
The Relation between Histopathologic Findings on Surgical Specimen and Outcomes in Patients with N2 Positive Stage IIIA Non-Small Cell Lung Cancer Receiving Preoperative Concurrent Radiochemotherapy and SurgeryBo Kyong Kim, Kyoung Ju Kim, Yong Chan Ahn, et al.
Korean Journal of Pathology|March 15, 2014
Usual interstitial pneumonia with lung cancer: clinicopathological analysis of 43 casesDae Hyun Song, In Ho Choi, Sang Yun Ha, et al.
Plos One|March 4, 2014
Quantitative CT variables enabling response prediction in neoadjuvant therapy with EGFR-TKIs: are they different from those in neoadjuvant concurrent chemoradiotherapy?Yousun Chong, Jae-Hun Kim, Ho Yun Lee, et al.
Diagnostic Cytopathology|November 27, 2014
Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutationsDae Hyun Song, Boram Lee, Yooju Shin, et al.
Cancers|June 24, 2022
The High Proportion of Discordant <i>EGFR</i> Mutations among Multiple Lung TumorsHyunwoo Lee, Jin Hee Park, Joungho Han, et al.
Radiology|July 26, 2012
Solitary pulmonary nodular lung adenocarcinoma: correlation of histopathologic scoring and patient survival with imaging biomarkersHo Yun Lee, Ji Yun Jeong, Kyung Soo Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
HIP1-ALK, a novel fusion protein identified in lung adenocarcinomaMineui Hong, Ryong Nam Kim, Ji-Young Song, et al.
Pageof 32

Showing results (241-250 of 313) with videos related to

Sort By:
Pageof 32
Cancer|January 7, 2010
Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarrayHyeong Su Kim, Yeon Hee Park, Jeeyun Lee, et al.
Cancer|July 16, 2008
ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapyIn Gyu Hwang, Myung Ju Ahn, Byeong Bae Park, et al.
Transplantation|May 15, 2007
Improvement of kidney failure with fetal kidney precursor cell transplantationSang-Soo Kim, Heung Jae Park, Joungho Han, et al.
Cancer Research and Treatment|December 19, 2015
The Relation between Histopathologic Findings on Surgical Specimen and Outcomes in Patients with N2 Positive Stage IIIA Non-Small Cell Lung Cancer Receiving Preoperative Concurrent Radiochemotherapy and SurgeryBo Kyong Kim, Kyoung Ju Kim, Yong Chan Ahn, et al.
Korean Journal of Pathology|March 15, 2014
Usual interstitial pneumonia with lung cancer: clinicopathological analysis of 43 casesDae Hyun Song, In Ho Choi, Sang Yun Ha, et al.
Plos One|March 4, 2014
Quantitative CT variables enabling response prediction in neoadjuvant therapy with EGFR-TKIs: are they different from those in neoadjuvant concurrent chemoradiotherapy?Yousun Chong, Jae-Hun Kim, Ho Yun Lee, et al.
Diagnostic Cytopathology|November 27, 2014
Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutationsDae Hyun Song, Boram Lee, Yooju Shin, et al.
Cancers|June 24, 2022
The High Proportion of Discordant <i>EGFR</i> Mutations among Multiple Lung TumorsHyunwoo Lee, Jin Hee Park, Joungho Han, et al.
Radiology|July 26, 2012
Solitary pulmonary nodular lung adenocarcinoma: correlation of histopathologic scoring and patient survival with imaging biomarkersHo Yun Lee, Ji Yun Jeong, Kyung Soo Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
HIP1-ALK, a novel fusion protein identified in lung adenocarcinomaMineui Hong, Ryong Nam Kim, Ji-Young Song, et al.
Pageof 32